Abstract
A 2-year-old male with chronic kidney disease with secondary hyperparathyroidism developed hypercalcemia while receiving calcitriol, without achieving a serum parathyroid hormone concentration within the goal range. Cinacalcet 15 mg (1.2 mg/kg), crushed and administered via gastrostomy tube, was added to the patient’s therapy. This therapy was effective in achieving targeted laboratory parameters in our patient despite instructions in the prescribing information that cinacalcet should always be taken whole.
| Original language | American English |
|---|---|
| Journal | Journal of Pediatric Pharmacology and Therapy |
| Volume | 19 |
| DOIs | |
| State | Published - Jan 1 2014 |
Keywords
- chronic kidney disease
- cinacalcet
- hypercalcemia
- secondary hyperparathyroidism
Disciplines
- Pediatrics
- Pharmaceutics and Drug Design
- Pharmacy and Pharmaceutical Sciences